LSX Investival Showcase Hybrid (white)

CONNECTING LIFE SCIENCE CORPORATES

WITH CAPITAL AND PARTNERS


Showcasing investable innovation across biotech, medtech and healthtech.


6th Annual Investment Showcase


8-15 November 2021 | Virtual
15 November 2021 | Physical 1:1 Partnering | Hilton Waldorf | London

 

Partnered with     Jefferies

DOWNLOAD BROCHURE

 

REGISTER NOW

Already registered?
Login to the virtual platform here and follow instructions

What is Inv€$tival ShowcaseTM


Returning for its sixth year, LSX’s Inv€$tival Showcase directly connects life science corporates to global capital and partners. In 2021, Inv€$tival ShowcaseTM is delivered as a hybrid event, blending the best of both virtual and physical! 

An international showcase of early, growth stage and public life science and health technology companies, Inv€$tival ShowcaseTM provides an unrivalled opportunity to pitch, profile and connect with investors and partners brought together during the biggest fortnight in European life sciences investment. The company showcases will highlight and promote the most exciting and innovative biotech, medtech, health technology and consumer health companies across Europe and beyond.

The online experience (8-15th November) features everything from the physical event and more! Hear from, connect, network and schedule 1:1 video meetings with global investors, corporates and strategic partners.

PLUS, PHYSICAL PARTNERING IS BACK!!!

A day of physical 1:1s, held at the Waldorf Hilton Hotel London (15th November), provides an in-person day of 1:1 meetings and an exclusive networking drinks function for executives making the trip to the capital.

Inv€$tival ShowcaseTM continues its exclusive partnership with global investment bank Jefferies, running the days before the Jefferies London Healthcare Conference.

 

Therapeutic & Technology Showcase Focus


LSX Biotech

LSX Medtech

LSX Healthtech

 

DOWNLOAD BROCHURE

Part of the most important fortnight in European healthcare investment

Agenda at a Glance


Investival 2021 Agenda at a Glance


Meet our speakers


Tim Haines, Managing Partner, Abingworth

Tim Haines

Managing Partner
Abingworth
Juliette Audet, Partner, Forbion

Juliette Audet

Partner
Forbion
Naveed Siddiqi, Senior Partner, Novo Ventures

Naveed Siddiqi

Senior Partner
Novo Ventures
Alexandra Zemp, Partner, McKinsey & Company

Alexandra Zemp

Partner
McKinsey & Company
Janke Dittmer, General Partner, Gilde Healthcare 300x

Janke Dittmer

General Partner
Gilde Healthcare
Katja Rosenkranz, Partner, V-Bio Ventures

Katja Rosenkranz

Partner
V-Bio Ventures
Junaid Bajwa, Chief Medical Scientist, Microsoft Research

Junaid Bajwa

Chief Medical Scientist
Microsoft Research
Tanja Dowe, CEO, Debiopharm Innovation Fund

Tanja Dowe

CEO
Debiopharm Innovation Fund
David Germonpré, Partner, MTIP

David Germonpré

Partner
MTIP
Diana Saraceni, Managing Partner, Panakès Partners

Diana Saraceni

Managing Partner
Panakès Partners
Florian Muellershausen, Managing Partner, Novartis Venture Fund

Florian Muellershausen

Managing Partner
Novartis Venture Fund
Martin Pfister, Investment Manager, High-Tech Grunderfonds

Martin Pfister

Investment Manager
High-Tech Grunderfonds

SEE ALL SPEAKERS


Key Partners


Event Partner


Jefferies

Knowledge Partner


McKinsey & company

Gold Partners


Baker McKenzie

Bird & Bird

Covington

Iowa Economic Development Authority

Latham & Watkins

Mintz

Pinsent Masons

Sidley Austin

2021 Key Event Stats


700+
ONLINE & PHYSICAL PARTICIPANTS
200+
INVESTORS, STRATEGICS & PHARMA
400+
BIOTECH, MEDTECH, HEALTHTECH
& DEEPTECH COMPANIES
75+
COMPANY SHOWCASES
HYBRID 1:1
ONLINE VIDEO MEETINGS IN ADDITION TO IN-PERSON PARTNERING
3HR RECEPTION
IN-PERSON EVENING NETWORKING DRINKS
Female Founders

Networking, Dialogue And Mentorship For Women In Health And Life Sciences
Members save 25% off all LSX events.

FIND OUT MORE

Subscribe to hear speaker announcements, ticket offers and more